Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Calithera Biosciences Inc CALA

Healthcare Biotechnology
Calithera Biosciences, Inc. is a shell company. The Company is winding up its operations. The Company is seeking to sell all of its clinical assets and programs. The Company has not generated any revenue.

Recent & Breaking News (GREY:CALA)

Calithera Biosciences Reports First Quarter 2021 Financial Results and Recent Highlights

GlobeNewswire May 6, 2021

Calithera Biosciences to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021

GlobeNewswire April 30, 2021

Results from Calithera Biosciences' CANTATA Study to Be Presented at 2021 ASCO Annual Meeting

GlobeNewswire April 28, 2021

Calithera Biosciences Reports Fourth Quarter 2020 Financial Results and Recent Highlights

GlobeNewswire March 16, 2021

UPDATE - Calithera Biosciences to Report Fourth Quarter 2020 Financial Results on Tuesday, March 16, 2021

GlobeNewswire March 12, 2021

Calithera Biosciences to Report Fourth Quarter 2021 Financial Results on Tuesday, March 16, 2021

GlobeNewswire March 10, 2021

Calithera to Present at the H.C. Wainwright Virtual Global Life Sciences 2021 Conference

GlobeNewswire March 2, 2021

Calithera to Participate in the 10th Annual SVB Leerink Global Healthcare Conference

GlobeNewswire February 22, 2021

INCB001158 Biliary Tract Cancer Data to be Presented at 2021 Virtual ASCO Gastrointestinal Cancers Symposium

GlobeNewswire January 11, 2021

Calithera to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference

GlobeNewswire January 5, 2021

Calithera Biosciences Reports CANTATA Study of Telaglenastat in Renal Cell Carcinoma Did Not Achieve Primary Endpoint

GlobeNewswire January 4, 2021

Calithera Biosciences Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire December 31, 2020

Calithera Biosciences Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire December 2, 2020

Calithera to Participate in Jefferies Virtual Healthcare Conference and SVB Leerink Oncology 1x1 Day

GlobeNewswire November 11, 2020

Calithera Biosciences Presents New Preclinical Data for CB-668 at Society for Immunotherapy of Cancer (SITC) 2020 Annual Meeting

GlobeNewswire November 9, 2020

Calithera Biosciences Reports Third Quarter 2020 Financial Results and Recent Highlights

GlobeNewswire November 5, 2020

Calithera Biosciences Announces Expansion of Ongoing Clinical Trial Evaluating Telaglenastat in Combination with palbociclib (IBRANCE®)

GlobeNewswire November 4, 2020

Calithera Biosciences Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire November 2, 2020

Calithera Biosciences Awarded up to $2.4M from Cystic Fibrosis Foundation to Support Clinical Development of Arginase Inhibitor, CB-280

GlobeNewswire November 2, 2020

Calithera Biosciences to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020

GlobeNewswire October 29, 2020